Home-based brain stimulation for treating ADHD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of home-based transcranial direct current stimulation (tDCS) over four weeks to improve symptoms of ADHD and cognitive control. It aims to determine the relationship between tDCS dosage and therapeutic outcomes, while also assessing the feasibility and acceptability of this home-based approach. By eliminating the need for daily hospital visits, the study seeks to enhance access to advanced treatment options for a broader population of ADHD patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male and female outpatients 18-65 years of age
2. A diagnosis of ADD/ADHD or meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.

Exclusion Criteria:

1. Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, VP shunt, pacemakers, pregnancy.
2. Active substance dependence (except for tobacco).
3. Pregnant or nursing females.
4. Inability to participate in testing procedures.
5. Premorbid neurological conditions (including neurovascular and neurodegenerative diseases such as traumatic brain injury, stroke, Parkinson's, AD and other dementias) and severe psychiatric disorders (bipolar disorder, schizophrenia).

Where it's running

• Massachusetts General Hospital
  Charlestown, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Joan Camprodon, MD, PHD, MPH — MGB: Division of Neuropsychiatry and Neuromodulation
• Study coordinator: DNN Inbox
• Email: mghdnn@mgh.harvard.edu
• Phone: 6177265348

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining the link between motor skills and sensory processing in children aged 4 to 11

  This study looks at how motor skills and sensory processing are connected in children aged 4 to 11, including those with conditions like Autism, ADHD, and Developmental Coordination Disorder.

  Recruiting University of Vic - Central University of Catalonia · Vic · NCT06764810

• Sulforaphane for Children Aged 6 to 12 With ADHD

  This study tests whether sulforaphane from broccoli helps reduce inattention and hyperactivity in children with ADHD compared with a placebo.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06594536

• Digital therapy using neurofeedback for treating ADHD in children

  This study is testing a new iPad game that uses neurofeedback and executive function training to see if it can help children aged 6 to 12 with ADHD improve their attention and thinking skills.

  Recruiting at 2 sites Changhai Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT06369714

• Using Dyanavel XR to treat fatigue in adults with ADHD

  This study is testing if Dyanavel XR can help adults with ADHD feel less tired over 10 weeks compared to a placebo.

  Recruiting Phase 4 Rochester Center for Behavioral Medicine · Rochester Hills, Michigan · NCT06248229

• Using weighted blankets to improve sleep in children with ADHD

  This study is testing whether using weighted blankets can help children with ADHD, ages 5 to 12, sleep better.

  Recruiting University Hospital Bispebjerg and Frederiksberg · Frederiksberg · NCT06194162

• Comparing Lisdexamphetamine and Methylphenidate for Kids with ADHD and Type 1 Diabetes

  This study is testing whether two different medications can help kids aged 8 to 16 with both ADHD and Type 1 Diabetes feel better and manage their symptoms more effectively.

  Recruiting Phase 2 Medical University of Lodz · Lodz, Łódź Voivodeship · NCT05957055

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.